US Stock MarketDetailed Quotes
LUNG Pulmonx
- 6.700
- -0.180-2.62%
Trading Dec 27 15:30 ET
264.57MMarket Cap-4.56P/E (TTM)
6.880High6.500Low106.56KVolume6.800Open6.880Pre Close707.60KTurnover0.28%Turnover RatioLossP/E (Static)39.49MShares14.83552wk High2.82P/B253.40MFloat Cap5.46052wk Low--Dividend TTM37.82MShs Float69.478Historical High--Div YieldTTM5.52%Amplitude4.070Historical Low6.640Avg Price1Lot Size
About Pulmonx Company
Pulmonx Corp. is a medical technology company, which engages in the provision of interventional pulmonology, planning tools and treatments for obstructive lung diseases. It operates through the United States, Europe, Middle East, Africa, Asia Pacific, and Other International segments. The company was founded by Rodney Perkins on December 26, 1995 and is headquartered in Redwood City, CA.
Company Profile
SymbolLUNG
Company NamePulmonx
Listing DateOct 1, 2020
Issue Price19.00
Founded1995
CEOMr. Steven S. Williamson
MarketNASDAQ
Employees279
Fiscal Year Ends12-31
Address700 Chesapeake Drive
CityRedwood City
ProvinceCalifornia
CountryUnited States of America
Zip Code94063
Phone1-650-364-0400
Websitehttp://www.pulmonx.com
Company Executives
- Name
- Position
- Salary
- Steven S. Willian
- Director, President and Chief Executive Officer
- --
- Geoffrey Beran Rose
- Chief Commercial Officer
- 1.96M
- Mehul Joshi
- Chief Financial Officer and Principal Accounting Officer
- --
- John McKune
- Vice President, Finance and Corporate Controller
- --
- Dana G. Mead, Jr
- Chairman of the Board
- 228.21K
- Glendon E. French
- Director
- 5.80M
- Georgia Garinois-Melenikiotou
- Independent Director
- 213.21K
- Tiffany Sullivan
- Independent Director
- 198.21K
- Thomas W. Burns
- Independent Director
- 200.71K
- Daniel P. Florin
- Independent Director
- 220.71K
- Richard Ferrari
- Independent Director
- 213.21K
- David A. Lehman
- General Counsel
- 2.64M
Heat List
US
Overall
Symbol
Price
% Chg
No Data
